|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$207,021,051 |
|
|
Indirect Value
|
$177,439,906 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$384,460,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-23 |
4 |
B |
$0.92 |
$44,390 |
I/I |
48,250 |
4,769,272 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-26 |
4 |
B |
$0.92 |
$21,620 |
I/I |
23,500 |
4,792,772 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-27 |
4 |
B |
$0.91 |
$9,009 |
I/I |
9,900 |
4,802,672 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-28 |
4 |
B |
$0.90 |
$5,104 |
I/I |
5,671 |
4,808,343 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-05 |
4 |
B |
$0.77 |
$389,600 |
I/I |
505,974 |
5,314,317 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-06 |
4 |
B |
$0.63 |
$88,200 |
I/I |
140,000 |
5,454,317 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-11 |
4 |
B |
$0.77 |
$25,486 |
I/I |
33,099 |
5,487,416 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-12 |
4 |
B |
$0.78 |
$182,764 |
I/I |
234,313 |
5,721,729 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-13 |
4 |
B |
$0.86 |
$80,332 |
I/I |
93,409 |
5,815,138 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-16 |
4 |
B |
$0.95 |
$5,130 |
I/I |
5,400 |
5,820,538 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-17 |
4 |
B |
$0.95 |
$190 |
I/I |
200 |
5,820,738 |
1.42 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-23 |
4 |
B |
$0.93 |
$60,324 |
I/I |
64,865 |
5,885,603 |
1.5 |
- |
|
BIOL |
Biolase Inc |
|
|
2020-02-11 |
4 |
S |
$0.60 |
$784,759 |
I/I |
(1,307,931) |
739,820 |
0 |
% |
|
HNSN |
Hansen Medical Inc |
Director |
|
2013-08-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,505,546 |
|
- |
|
HNSN |
Hansen Medical Inc |
Director |
|
2013-08-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,319,769 |
|
- |
|
HNSN |
Hansen Medical Inc |
Director |
|
2014-02-26 |
4 |
OE |
$1.23 |
$4,605,236 |
I/I |
3,744,094 |
13,233,640 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
10% Owner |
|
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,044,578 |
1,044,578 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
10% Owner |
|
2015-07-28 |
4 |
B |
$15.00 |
$300,000 |
I/I |
20,000 |
1,279,903 |
1.5 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
10% Owner |
|
2015-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
208,325 |
1,252,903 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
10% Owner |
|
2017-02-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,338,671 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
798,767 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,886,590 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-04 |
4 |
B |
$9.04 |
$1,808,260 |
D/D |
200,000 |
3,090,890 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-05 |
4 |
B |
$4.50 |
$525,000 |
D/D |
110,000 |
3,200,890 |
2.45 |
- |
|
634 Records found
|
|
Page 11 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|